Dabigatran etexilate Recruiting Phase 3 Trials for Cerebral Venous Thrombosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03217448The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis